Search Orphan Drug Designations and Approvals
-
| Generic Name: | Levocarnitine | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Name: | Carnitor | ||||||||||||||||
| Date Designated: | 09/06/1988 | ||||||||||||||||
| Orphan Designation: | Treatment of manifestations of carnitine deficiency in patients with end stage renal disease who require dialysis. | ||||||||||||||||
| Orphan Designation Status: | Designated/Approved | ||||||||||||||||
| Sponsor: |
Leadiant Biosciences, Inc. 9841 Washingtonian Blvd Suite 500 Gaithersburg, Maryland 20878 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
| 1 | Generic Name: | Levocarnitine |
|---|---|---|
| Trade Name: | Carnitor | |
| Marketing Approval Date: | 12/15/1999 | |
| Approved Labeled Indication: | Prevention and treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis. | |
| Exclusivity End Date: | 12/15/2006 | |
| Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







